Lisa Schlager[email protected]GuidelineIs the new Medicare NGS payment policy really a win for patients?The implications of the new policy, however, are less positive than what appears at the surface. Patients seeking germline testing are only slightly better off now than they were two years ago, before the NCD was initiated.February 4, 2020Page 1 of 1Top StoriesFDA ClearanceBioMĂ©rieux gets FDA 510(k) clearance, CLIA waiver approval for panelBioMĂ©rieux's Biofire Spotfire Respiratory/Sore Throat Panel has received dual FDA 510(k) clearance and Clinical Laboratory Improvement Amendments (CLIA) waiver approval.Skin CancerCastle Biosciences shares melanoma test study data at SSO 2024Artificial IntelligenceIbex presents new study data for AI-powered cancer diagnostics platformMergers & AcquisitionsAbbVie to buy Landos Biopharma for up to $212MCancerStudy sheds light on the organization of immune cells in tumors